Key result
Cardiorenal syndrome classification, pathophysiology, and treatments require further validation through dedicated randomized trials.
Cardiorenal Syndrome has become one pressing issue as far as hospitalizations are concerned [...].
No takes yet. Share an insight, caveat, or question.
Rainer U. Pliquett (2022) conducted an editorial in Cardiorenal Syndrome. Cardiorenal syndrome classification, pathophysiology, and current treatments require further validation through dedicated clinical randomized trials.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: